Everolimus in Treating Cutaneous T-cell Lymphoma
Clinical trial NCT01637090 · TERMINATED
Trial details
- NCT number
- NCT01637090
- Sponsor
- Adam Lerner
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2015-05-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.